Patents by Inventor Jorge GONZÁLEZ-CANUDAS

Jorge GONZÁLEZ-CANUDAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
    Patent number: 11951081
    Abstract: The present disclosure relates to metformin glycinate and methods of using metformin glycinate for the treatment of diseases including diabetes mellitus, obesity, dyslipidemia, diseases associated with IL-10 up-regulation, and diseases or disorders associated with elevated or increased ceramide levels. Pharmaceutical formulations comprising metformin glycinate are also disclosed.
    Type: Grant
    Filed: November 2, 2021
    Date of Patent: April 9, 2024
    Assignee: LABORATORIOS SILANES S.A. DE C.V.
    Inventor: Jorge González-Canudas
  • Metformin amino acid compounds and methods of using the same
    Patent number: 11510886
    Abstract: The present invention relates to metformin amino acid compounds (SLNs), pharmaceutical compositions thereof, and methods of using them for the treatment of hyperglycemia, diabetes, and Type 2 diabetes. The compounds can be synthesized using the processes disclosed herein.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: November 29, 2022
    Assignee: LABORATORIOS SILANES, S.A. DE C.V.
    Inventor: Jorge González-Canudas
  • METFORMIN GLYCINATE, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME
    Publication number: 20220296539
    Abstract: The present disclosure relates to metformin glycinate and methods of using metformin glycinate for the treatment of diseases including diabetes mellitus, obesity, dyslipidemia, diseases associated with IL-10 up-regulation, and diseases or disorders associated with elevated or increased ceramide levels. Pharmaceutical formulations comprising metformin glycinate are also disclosed.
    Type: Application
    Filed: November 2, 2021
    Publication date: September 22, 2022
    Inventor: Jorge GONZÁLEZ-CANUDAS
  • Metformin glycinate, pharmaceutical compositions comprising the same, and methods of using the same
    Patent number: 11185516
    Abstract: The present disclosure relates to metformin glycinate and methods of using metformin glycinate for the treatment of diseases including diabetes mellitus, obesity, dyslipidemia, diseases associated with IL-10 up-regulation, and diseases or disorders associated with elevated or increased ceramide levels. Pharmaceutical formulations comprising metformin glycinate are also disclosed.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: November 30, 2021
    Assignee: Laboratorios Silanes S.A. DE C.V.
    Inventor: Jorge González-Canudas
  • METFORMIN AMINO ACID COMPOUNDS AND METHODS OF USING THE SAME
    Publication number: 20200222343
    Abstract: The present invention relates to metformin amino acid compounds (SLNs), pharmaceutical compositions thereof, and methods of using them for the treatment of hyperglycemia, diabetes, and Type 2 diabetes. The compounds can be synthesized using the processes disclosed herein.
    Type: Application
    Filed: September 29, 2017
    Publication date: July 16, 2020
    Inventor: Jorge GONZÁLEZ-CANUDAS
  • METFORMIN GLYCINATE, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS OF USING THE SAME
    Publication number: 20200022930
    Abstract: The present disclosure relates to metformin glycinate and methods of using metformin glycinate for the treatment of diseases including diabetes mellitus, obesity, dyslipidemia, diseases associated with IL-10 up-regulation, and diseases or disorders associated with elevated or increased ceramide levels. Pharmaceutical formulations comprising metformin glycinate are also disclosed.
    Type: Application
    Filed: September 29, 2017
    Publication date: January 23, 2020
    Inventor: Jorge GONZÁLEZ-CANUDAS